Non-small Cell Lung Cancer Stage IB
1 clinical trials · Condition
◉ Watch Non-small Cell Lung Cancer Stage IB
| Record | Firm | Date |
|---|---|---|
| Neoadjuvant Therapy of Pembrolizumab + Ramucirumab for PD-L1 Positive Stage IB-IIIA Lung Cancer (EAST ENERGY) (NCT04040361) | Masahiro Tsuboi | 2019-11-30 |
Track Non-small Cell Lung Cancer Stage IB automatically
Every clearance here is in the API, with alerts when new ones post.